Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProQR Therapeutics N.V. - Ordinary Shares (NQ: PRQR )

2.420 +0.150 (+6.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProQR Therapeutics N.V. - Ordinary Shares

< Previous 1 2 3 4 Next >
Bluebird Bio To Rally Around 267%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
ProQR Announces Third Quarter 2023 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference
From ProQR Therapeutics N.V.
Via GlobeNewswire
4 Analysts Have This to Say About ProQR Therapeutics
Via Benzinga
ProQR Therapeutics Provides Update on Ophthalmic Assets
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Second Quarter 2023 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
Analyst Ratings for ProQR Therapeutics
Via Benzinga
Recap: ProQR Therapeutics Q1 Earnings
Via Benzinga
Earnings Outlook For ProQR Therapeutics
Via Benzinga
ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces First Quarter 2023 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Upcoming Investor Conferences in April and May
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S.... 
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
Via Benzinga
S&P 500 Up 1%; Bluebird Bio Shares Plummet
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also... 
Via Benzinga
Why Shares of ProQR Therapeutics Dropped on Wednesday
The clinical-stage biotech released fourth-quarter and full-year earnings. 
Via The Motley Fool
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million. 
Via Benzinga
Nasdaq Rises 1%; US Pending Home Sales Increase In February
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P... 
Via Benzinga
US Stocks Open Higher, Dow Jumps Over 200 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%... 
Via Benzinga
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR to Present at Upcoming Scientific and Industry Conferences
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023
From ProQR Therapeutics N.V.
Via GlobeNewswire
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
Oppenheimer cut CarMax, Inc. (NYSE: KMX) price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market... 
Via Benzinga
Dow Dips 600 Points; AMC Entertainment Shares Plunge
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.